• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脂异常的继发原因。

Secondary causes of dyslipidemia.

机构信息

Michigan State University, East Lansing, MI, USA.

出版信息

Am J Cardiol. 2012 Sep 15;110(6):823-5. doi: 10.1016/j.amjcard.2012.04.062. Epub 2012 Jun 2.

DOI:10.1016/j.amjcard.2012.04.062
PMID:22658245
Abstract

The causes of the lipid disorders in patients referred to specialty clinics for difficult-to-treat dyslipidemias are likely multifactorial. However, the importance of evaluating for secondary causes is unclear. The investigators performed a chart review of new patients referred to the University of Michigan Lipid Clinic from January 2004 to June 2011 (n = 824) to evaluate for the prevalence of several secondary causes of dyslipidemia. In addition to lipoproteins, new patients were assessed for secondary dyslipidemias by a standardized protocol consisting of laboratory testing, a nutritional evaluation, and medical history. These data were evaluated to determine the prevalence of several secondary causes of dyslipidemia. A total of 363 separate factors were identified in the 824 patients that were thought to be potential secondary causes of dyslipidemia. Because some patients (n = 83 [10%]) had multiple conditions, there were 230 (28% of the cohort) with ≥1 potential secondary dyslipidemias. The most common conditions were excessive alcohol intake (n = 82 [10%]), uncontrolled diabetes mellitus (n = 68 [8%]), and overt albuminuria. Although other causes occurred less frequently (each individually found in <5% of patients), altogether they were present in a substantial portion of patients (n = 102 [12%]). In conclusion, nearly 1/3 of patients referred to a specialty clinic had identifiable secondary conditions plausibly contributing to their dyslipidemia. Numerous disorders were identified, with diabetes mellitus and excessive alcohol being the most common.

摘要

导致患者脂质紊乱的原因可能是多因素的,这些患者被转介到专门的诊所治疗治疗困难的血脂异常。然而,评估继发性病因的重要性尚不清楚。研究人员对 2004 年 1 月至 2011 年 6 月期间被转介到密歇根大学脂类诊所的新患者(n=824)进行了图表回顾,以评估几种血脂异常的继发性病因的发生率。除了脂蛋白,新患者还通过标准化方案进行了继发性血脂异常的评估,该方案包括实验室检查、营养评估和病史。这些数据被评估以确定几种继发性血脂异常的发生率。在 824 名患者中,共发现了 363 个单独的因素,这些因素被认为是血脂异常的潜在继发性病因。由于一些患者(n=83[10%])存在多种情况,因此有 230 名(队列的 28%)患者存在≥1 种潜在的继发性血脂异常。最常见的情况是过度饮酒(n=82[10%])、未控制的糖尿病(n=68[8%])和明显的白蛋白尿。尽管其他原因的发生率较低(每种情况在<5%的患者中发现),但它们在很大一部分患者中存在(n=102[12%])。总之,近 1/3 被转介到专门诊所的患者存在可识别的继发性疾病,这些疾病可能是导致其血脂异常的原因。发现了许多疾病,其中糖尿病和过度饮酒最为常见。

相似文献

1
Secondary causes of dyslipidemia.血脂异常的继发原因。
Am J Cardiol. 2012 Sep 15;110(6):823-5. doi: 10.1016/j.amjcard.2012.04.062. Epub 2012 Jun 2.
2
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.法国全科医疗中接受降脂治疗患者的混合性血脂异常:一项观察性研究。
Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003.
3
Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients.泰国糖尿病登记项目:泰国糖尿病患者血脂异常的现状
J Med Assoc Thai. 2006 Aug;89 Suppl 1:S60-5.
4
Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.加拿大初级保健中血脂异常的患病率及治疗:一项回顾性队列分析。
Clin Ther. 2007 Apr;29(4):742-50. doi: 10.1016/j.clinthera.2007.04.009.
5
Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.中国农村高血压成年人血脂表型的患病率及其与糖尿病和肥胖的关联。
Heart Lung. 2009 Jan-Feb;38(1):17-24. doi: 10.1016/j.hrtlng.2008.02.001.
6
Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra state south-east Nigeria.尼日利亚东南部阿南布拉州显性糖尿病肾病成年糖尿病患者血脂异常的患病率
Niger J Clin Pract. 2011 Apr-Jun;14(2):171-5. doi: 10.4103/1119-3077.84009.
7
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.动脉粥样硬化多民族研究(MESA)中的血脂异常患病率、治疗与控制:性别、种族与冠状动脉钙化
Circulation. 2006 Feb 7;113(5):647-56. doi: 10.1161/CIRCULATIONAHA.105.552737.
8
Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.冠心病血脂异常管理中性别差异的回顾性研究:对来自马里兰州一家健康维护组织的患者数据的分析
Clin Ther. 2006 Apr;28(4):591-9. doi: 10.1016/j.clinthera.2006.04.012.
9
Dyslipidemias in type 2 diabetes mellitus patients in Nnewi South-East Nigeria.尼日利亚东南部纽维2型糖尿病患者的血脂异常情况
Ann Afr Med. 2011 Oct-Dec;10(4):285-9. doi: 10.4103/1596-3519.87045.
10
[Secondary dyslipidemias and their treatment].[继发性血脂异常及其治疗]
Vnitr Lek. 2007 Apr;53(4):396-400.

引用本文的文献

1
Dyslipidemia and associated factors among hypertensive patients in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚高血压患者的血脂异常及相关因素:一项系统评价和荟萃分析。
BMC Cardiovasc Disord. 2025 May 15;25(1):367. doi: 10.1186/s12872-025-04808-3.
2
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine.英国血脂检测与报告的标准化;英国心脏协会(HEART UK)与检验医学协会联合声明
Ann Clin Biochem. 2025 Jul;62(4):257-286. doi: 10.1177/00045632251315303. Epub 2025 Jan 31.
3
Changes in Haematological Parameters and Lipid Profiles in Diabetes Mellitus: A Literature Review.
糖尿病患者血液学参数和血脂谱的变化:文献综述
Cureus. 2024 Jul 9;16(7):e64201. doi: 10.7759/cureus.64201. eCollection 2024 Jul.
4
Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin.基于初榨椰子油的纳米结构化脂质载体可增强瑞舒伐他汀的降血脂作用。
Int J Nanomedicine. 2024 Aug 5;19:7945-7961. doi: 10.2147/IJN.S463750. eCollection 2024.
5
Smoothed quantile residual life regression analysis with application to the Korea HIV/AIDS cohort study.平滑分位数残差寿命回归分析及其在韩国艾滋病毒/艾滋病队列研究中的应用。
BMC Med Res Methodol. 2024 Feb 17;24(1):44. doi: 10.1186/s12874-024-02159-9.
6
Association between gestational weight gain and chronic disease risks in later life.妊娠体重增加与晚年慢性疾病风险的关联。
Sci Rep. 2024 Jan 5;14(1):659. doi: 10.1038/s41598-023-50844-4.
7
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.日本动脉粥样硬化协会(JAS)2022年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19.
8
New-onset dyslipidemia in adult cancer survivors from medically underserved areas: a 10-year retrospective cohort study.医疗资源不足地区成年癌症幸存者新发血脂异常:一项长达 10 年的回顾性队列研究。
BMC Cancer. 2023 Sep 26;23(1):904. doi: 10.1186/s12885-023-11384-2.
9
Advances in Treatment of Dyslipidemia.血脂异常治疗进展。
Int J Mol Sci. 2023 Aug 27;24(17):13288. doi: 10.3390/ijms241713288.
10
Obesity, Lipid Profile and Cytokines in Spondyloarthritis.脊柱关节炎中的肥胖、血脂谱与细胞因子
Indian J Endocrinol Metab. 2022 Jul-Aug;26(4):348-353. doi: 10.4103/ijem.ijem_176_22. Epub 2022 Sep 20.